Crispr Therapeutics Ag reported raising $35 Million in an initial SEC Form D filing, from an offering of $35 Million
Amount Raised
$35 Million
Round Type
Venture
ZugBiotechnologyHealthcareHealth CareGeneticsTherapeuticsQuick answer
Crispr Therapeutics raised $35 Million in a funding round, dated November 4, 2016. Crispr Therapeutics is based in Zug, Zug, Switzerland.
- How much did Crispr Therapeutics raise?
- Crispr Therapeutics raised $35 Million in a funding round on November 4, 2016.
- What does Crispr Therapeutics do?
- CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
- Where is Crispr Therapeutics based and how big is it?
- Crispr Therapeutics is based in Zug, Zug, Switzerland. Fundz records about 344 employees.
- Who are the decision-makers at Crispr Therapeutics?
- Fundz holds 1 contact at Crispr Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Genetics around the same time
Companies in the same sectors as Crispr Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- ShockWave Medical raised $45M on November 22, 2016.
- TuHURA Biosciences raised an undisclosed amount on November 4, 2016.
- BioCardia raised $36M on November 4, 2016.
- Ocugen raised $30M on October 12, 2016.
- Galectin raised $1.5M (Seed) on September 28, 2016.
- INTRINSIC THERAPEUTICS raised $18M on December 16, 2016.
Who to call at Crispr Therapeutics, and when
A new round usually means Crispr Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Crispr Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Crispr Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Crispr Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Crispr Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Crispr Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.